Multi-Agency Informational Meeting Concerning Compliance With the Federal Select Agent Program; Public Webcast, 56845-56846 [2012-22653]
Download as PDF
<![CDATA[
56845
Federal Register / Vol. 77, No. 179 / Friday, September 14, 2012 / Notices
the corresponding dollar amounts.
These forms are needed to provide
borrowers with information on the cost
of their loan(s) and to determine which
lenders may have excessive
delinquencies and defaulted loans.
Number of
respondents
Instrument
Responses
per
respondent
The annual estimate of burden is as
follows:
Total
responses
Hours per
response
Total burden
hours
Disclosure: Repayment Schedule HRSA 502–1, 2 .............
Reporting: Call Report HRSA 512 .......................................
7
15
50
4
350
60
.50
.75
175
45
Total Reporting and Disclosure ....................................
22
........................
410
........................
220
Email comments to
paperwork@hrsa.gov, or mail the HRSA
Reports Clearance Officer, Room 10–29,
Parklawn Building, 5600 Fishers Lane,
Rockville, MD 20857. Written comments
should be received within 60 days of
this notice.
Dated: September 10, 2012.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2012–22707 Filed 9–13–12; 8:45 am]
BILLING CODE 4165–15–P
Centers for Disease Control and
Prevention
Meeting of the Community Preventive
Services Task Force (Task Force)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC)
announces the next meeting of the
Community Preventive Services Task
Force (Task Force). The Task Force is
independent and nonfederal. Its
members are nationally known leaders
in public health practice, policy, and
research, and are appointed by the CDC
Director. The Task Force was convened
in 1996 by the Department of Health
and Human Services (HHS) to assess the
effectiveness of community,
environmental, population, and
healthcare system interventions in
public health and health promotion.
During this meeting, the Task Force will
consider the findings of systematic
reviews and issue recommendations and
findings to help inform decision making
about policy, practice, and research in a
wide range of U.S. settings. The Task
Force’s recommendations, along with
the systematic reviews of the scientific
evidence on which they are based, are
compiled in the Guide to Community
Preventive Services (Community Guide).
mstockstill on DSK4VPTVN1PROD with NOTICES
VerDate Mar<15>2010
16:39 Sep 13, 2012
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
The Task Force Meeting
will be held at the Emory Conference
Center at 1615 Clifton Road, Atlanta, GA
30329. Information regarding logistics
will be available on the Community
Guide Web site (www.
thecommunityguide.org), Wednesday,
September 12, 2012.
Multi-Agency Informational Meeting
Concerning Compliance With the
Federal Select Agent Program; Public
Webcast
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
SUMMARY:
The meeting will be held on
Wednesday, October 10, 2012 from 8:30
a.m. to 5:30 p.m., EST and Thursday,
October 11, 2012 from 8:30 a.m. to 1
p.m. EST.
DATES:
Allyson Brown, The Community Guide
Branch, Epidemiology and Analysis
Program Office, Office of Surveillance,
Epidemiology, and Laboratory Services,
Centers for Disease Control and
Prevention, 1600 Clifton Road, MS–E–
69, Atlanta, Georgia 30333, phone: (404)
498–0937), email: CPSTF@cdc.gov.
Purpose: The purpose of the meeting
is for the Task Force to consider the
findings of systematic reviews and issue
recommendations and findings to help
inform decision making about policy,
practice, and research in a wide range
of U.S. settings.
Matters To Be Discussed: Matters to
be discussed: Tobacco, oral health and
cardiovascular disease.
Meeting Accessibility: This meeting is
open to the public, limited only by
space availability.
Dated: September 10, 2012.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2012–22654 Filed 9–13–12; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of public webcast.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the notice of
a public webcast concerning compliance
with the Federal Select Agent Program.
The purpose of this notice is to notify
all interested parties, including
individuals and entities possessing,
using, or transferring biological agents
and toxins listed in 7 CFR 331.3, 9 CFR
121.3 and 121.4, or 42 CFR 73.3 and
73.4, of the webcast. The webcast is
organized by the U.S. Department of
Agriculture’s Animal and Plant Health
Inspection Service (USDA/APHIS), the
Department of Health and Human
Services Centers for Disease Control and
Prevention (HHS/CDC), and the
Department of Justice’s Federal Bureau
of Investigation (FBI). Issues to be
discussed include changes to the select
agent regulations; occupational health,
information and physical security;
personnel suitability; Bioterrorism
Security Risk Assessment Form (FD–961
form); and changes to the Application
for Laboratory Registration for
Possession, Use, and Transfer of Select
Agents and Toxins (APHIS/CDC Form
1).
SUMMARY:
The webcast will be held on
Friday, November 16, 2012 from 9 a.m.
to 5 p.m. EST. All who wish to join the
webcast must register by October 16,
2012. Registration instructions are
found on the Federal Select Agent
Program Web site, https://
www.selectagents.gov.
DATES:
Frm 00038
Fmt 4703
Sfmt 4703
E:\FR\FM\14SEN1.SGM
14SEN1
56846
Federal Register / Vol. 77, No. 179 / Friday, September 14, 2012 / Notices
The webcast will be
broadcast from the Centers for Disease
Control and Prevention facility, 1600
Clifton Rd. NE., Atlanta, GA 30329.
FOR FURTHER INFORMATION CONTACT:
CDC: LCDR. Jacinta Smith, Division of
Select Agents and Toxins, Office of
Public Health Preparedness and
Response, Centers for Disease Control
and Prevention, 1600 Clifton Road, NE.,
MS A–46, Atlanta, GA 30333;
lrsat@cdc.gov.
APHIS: Dr. Lidia Carrera, APHIS
Select Agent Program, APHIS, 4700
River Road, Unit 2, Riverdale, MD
20737; Lidia.Carrera@aphis.usda.gov
SUPPLEMENTARY INFORMATION: Title II of
the Public Health Security and
Bioterrorism Preparedness and
Response Act of 2002, ‘‘Enhancing
Controls on Dangerous Biological
Agents and Toxins’’ (sections 201
through 231), provides for the regulation
of certain biological agents and toxins
by the Department of Health and Human
Services (subtitle A, sections 201–204)
and the Department of Agriculture
(subtitle B, sections 211–213).
Additionally, the statute provides for
interagency coordination between the
two departments regarding overlap
agents and toxins (subtitle C, section
221). For the Department of Health and
Human Services(HHS), the Centers for
Disease Control and Prevention (CDC)
oversees entities that possess, use or
transfer select agents and toxins that
have the potential to pose a severe
threat to public health and safety. The
U.S. Department of Agriculture’s
(USDA) Animal and Plant Health
Inspection Service (APHIS) has a
parallel program that oversees entities
that possess, use or transfer select agents
that have the potential to pose a severe
threat to animal or plant health, or to
animal or plant products . These two
programs constitute the Federal Select
Agent Program. The Federal Bureau of
Investigation’s (FBI) Criminal Justice
Information Services conducts security
risk assessments of (1) all individuals
and nongovernmental entities that
request to possess, use, or transfer select
agents and toxins, (2) all individuals
who need access to select agents and
toxins.
The webcast announced in this notice
is an opportunity for the regulated
community (i.e., registered entity
responsible officials, alternate
responsible officials, and entity owners)
and other interested individuals to
obtain specific regulatory guidance and
information on standards concerning
biosafety, biosecurity and incident
response issues related to the Federal
Select Agent Program. Representatives
mstockstill on DSK4VPTVN1PROD with NOTICES
ADDRESSES:
VerDate Mar<15>2010
16:39 Sep 13, 2012
Jkt 226001
from HHS/CDC, USDA/APHIS, and the
FBI will be present during the webcast
to address questions and concerns from
the web participants.
Updates on the changes to the select
agent regulations; occupational health,
information and physical security;
personnel suitability; FD–961 form, and
changes to the APHIS/CDC Form 1 are
among the issues that will be discussed.
A question and answer session will take
place after each topic.
Registration instructions are found on
the Federal Select Agent Program Web
site https://www.selectagents.gov.
Registration ends on October 16, 2012.
This is a webcast only event and there
will be no on-site participation at the
HHS/CDC broadcast facility.
Registration is required for
participation. This is a 100% webcast;
therefore, in person participation cannot
be accommodated.
Participants will be able to submit
questions during the webcast at
selectagentwkshp@cdc.gov. Closedcaptioning services will be provided
during the webcast.
Dated: September 10, 2012.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2012–22653 Filed 9–13–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2012–N–0937]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Clinical Laboratory
Improvement Amendments of 1988
Waiver Applications
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing an
opportunity for public comment on the
proposed collection of certain
information by the Agency. Under the
Paperwork Reduction Act of 1995 (the
PRA), Federal Agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension of an existing collection of
information, and to allow 60 days for
public comment in response to the
notice. This notice solicits comments on
collections of information associated
with Clinical Laboratory Improvement
SUMMARY:
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Amendments of 1988 waiver
applications.
Submit either electronic or
written comments on the collection of
information by November 13, 2012.
ADDRESSES: Submit electronic
comments on the collection of
information to https://
www.regulations.gov. Submit written
comments on the collection of
information to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. All
comments should be identified with the
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Under the
PRA (44 U.S.C. 3501–3520), Federal
Agencies must obtain approval from the
Office of Management and Budget
(OMB) for each collection of
information they conduct or sponsor.
‘‘Collection of information’’ is defined
in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA (44
U.S.C. 3506(c)(2)(A)) requires Federal
Agencies to provide a 60-day notice in
the Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information,
before submitting the collection to OMB
for approval. To comply with this
requirement, FDA is publishing notice
of the proposed collection of
information set forth in this document.
With respect to the following
collection of information, FDA invites
comments on these topics: (1) Whether
the proposed collection of information
is necessary for the proper performance
of FDA’s functions, including whether
the information will have practical
utility; (2) the accuracy of FDA’s
estimate of the burden of the proposed
collection of information, including the
validity of the methodology and
assumptions used; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques,
when appropriate, and other forms of
information technology.
DATES:
E:\FR\FM\14SEN1.SGM
14SEN1
]]>Agencies
[Federal Register Volume 77, Number 179 (Friday, September 14, 2012)]
[Notices]
[Pages 56845-56846]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22653]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Multi-Agency Informational Meeting Concerning Compliance With the
Federal Select Agent Program; Public Webcast
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of public webcast.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the notice of a
public webcast concerning compliance with the Federal Select Agent
Program. The purpose of this notice is to notify all interested
parties, including individuals and entities possessing, using, or
transferring biological agents and toxins listed in 7 CFR 331.3, 9 CFR
121.3 and 121.4, or 42 CFR 73.3 and 73.4, of the webcast. The webcast
is organized by the U.S. Department of Agriculture's Animal and Plant
Health Inspection Service (USDA/APHIS), the Department of Health and
Human Services Centers for Disease Control and Prevention (HHS/CDC),
and the Department of Justice's Federal Bureau of Investigation (FBI).
Issues to be discussed include changes to the select agent regulations;
occupational health, information and physical security; personnel
suitability; Bioterrorism Security Risk Assessment Form (FD-961 form);
and changes to the Application for Laboratory Registration for
Possession, Use, and Transfer of Select Agents and Toxins (APHIS/CDC
Form 1).
DATES: The webcast will be held on Friday, November 16, 2012 from 9
a.m. to 5 p.m. EST. All who wish to join the webcast must register by
October 16, 2012. Registration instructions are found on the Federal
Select Agent Program Web site, https://www.selectagents.gov.
[[Page 56846]]
ADDRESSES: The webcast will be broadcast from the Centers for Disease
Control and Prevention facility, 1600 Clifton Rd. NE., Atlanta, GA
30329.
FOR FURTHER INFORMATION CONTACT:
CDC: LCDR. Jacinta Smith, Division of Select Agents and Toxins,
Office of Public Health Preparedness and Response, Centers for Disease
Control and Prevention, 1600 Clifton Road, NE., MS A-46, Atlanta, GA
30333; lrsat@cdc.gov.
APHIS: Dr. Lidia Carrera, APHIS Select Agent Program, APHIS, 4700
River Road, Unit 2, Riverdale, MD 20737; Lidia.Carrera@aphis.usda.gov
SUPPLEMENTARY INFORMATION: Title II of the Public Health Security and
Bioterrorism Preparedness and Response Act of 2002, ``Enhancing
Controls on Dangerous Biological Agents and Toxins'' (sections 201
through 231), provides for the regulation of certain biological agents
and toxins by the Department of Health and Human Services (subtitle A,
sections 201-204) and the Department of Agriculture (subtitle B,
sections 211-213). Additionally, the statute provides for interagency
coordination between the two departments regarding overlap agents and
toxins (subtitle C, section 221). For the Department of Health and
Human Services(HHS), the Centers for Disease Control and Prevention
(CDC) oversees entities that possess, use or transfer select agents and
toxins that have the potential to pose a severe threat to public health
and safety. The U.S. Department of Agriculture's (USDA) Animal and
Plant Health Inspection Service (APHIS) has a parallel program that
oversees entities that possess, use or transfer select agents that have
the potential to pose a severe threat to animal or plant health, or to
animal or plant products . These two programs constitute the Federal
Select Agent Program. The Federal Bureau of Investigation's (FBI)
Criminal Justice Information Services conducts security risk
assessments of (1) all individuals and nongovernmental entities that
request to possess, use, or transfer select agents and toxins, (2) all
individuals who need access to select agents and toxins.
The webcast announced in this notice is an opportunity for the
regulated community (i.e., registered entity responsible officials,
alternate responsible officials, and entity owners) and other
interested individuals to obtain specific regulatory guidance and
information on standards concerning biosafety, biosecurity and incident
response issues related to the Federal Select Agent Program.
Representatives from HHS/CDC, USDA/APHIS, and the FBI will be present
during the webcast to address questions and concerns from the web
participants.
Updates on the changes to the select agent regulations;
occupational health, information and physical security; personnel
suitability; FD-961 form, and changes to the APHIS/CDC Form 1 are among
the issues that will be discussed. A question and answer session will
take place after each topic.
Registration instructions are found on the Federal Select Agent
Program Web site https://www.selectagents.gov. Registration ends on
October 16, 2012. This is a webcast only event and there will be no on-
site participation at the HHS/CDC broadcast facility. Registration is
required for participation. This is a 100% webcast; therefore, in
person participation cannot be accommodated.
Participants will be able to submit questions during the webcast at
selectagentwkshp@cdc.gov. Closed-captioning services will be provided
during the webcast.
Dated: September 10, 2012.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2012-22653 Filed 9-13-12; 8:45 am]
BILLING CODE 4163-18-P
